Department of Internal Medicine, Institute of Neurogastroenterology and Motility, Martin-Luther Hospital, Academic Teaching Institution of Charité - University Medical Center, Berlin, Germany.
Charité Center for Internal Medicine and Dermatology, Division of General Internal and Psychosomatic Medicine; Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
J Neurogastroenterol Motil. 2014 Apr 30;20(2):228-35. doi: 10.5056/jnm.2014.20.2.228.
BACKGROUND/AIMS: Carbohydrate malabsorption is frequent in patients with functional gastrointestinal disorders and in healthy volunteers and can cause gastrointestinal symptoms mimicking irritable bowel syndrome (IBS). The aim of this study was to investigate the prevalence of symptomatic lactose and fructose malabsorption in a large population of patients with IBS-like symptoms based on Rome II criteria.
Patients with unclear abdominal discomfort (n = 2,390) underwent lactose (50 g) and fructose (50 g) hydrogen (H2) breath tests and depending on the results further testing with 25 g fructose or 50 g glucose, or upper endoscopy with duodenal biopsies. Additionally, this population was investigated regarding the prevalence of small intestinal bacterial overgrowth (SIBO) based on glucose breath test and celiac disease.
Of the 2,390 patients with IBS-like symptoms, 848 (35%) were symptomatic lactose malabsorbers and 1,531 (64%) sympto-matic fructose malabsorbers. A combined symptomatic carbohydrate malabsorption was found in 587 (25%) patients. Severe fructose malabsorbers (pathologic 25 g fructose test) exhaled significantly higher H2 concentrations in the 50 g test than pa-tients with negative 25 g fructose test (P < 0.001). Out of 460/659 patients with early significant H2 increase in the lactose and fructose test who underwent a glucose breath test, 88 patients had positive results indicative of SIBO and they were sig-nificantly older than patients with negative test result (P < 0.01). Celiac disease was found in 1/161 patients by upper endoscopy.
Carbohydrate malabsorption is a frequent but underestimated condition in patients with IBS-like symptoms although diagnosis can be easily confirmed by H2 breath testing.
背景/目的:碳水化合物吸收不良在功能性胃肠疾病患者和健康志愿者中很常见,并且会导致类似肠易激综合征(IBS)的胃肠道症状。本研究的目的是根据罗马 II 标准,调查基于 IBS 样症状的大样本患者中症状性乳糖和果糖吸收不良的患病率。
848 例(35%)有症状乳糖吸收不良和 1531 例(64%)有症状果糖吸收不良患者接受了乳糖(50 g)和果糖(50 g)氢(H2)呼气试验,根据结果进一步进行 25 g 果糖或 50 g 葡萄糖检测,或上消化道内镜和十二指肠活检。此外,还根据葡萄糖呼气试验和乳糜泻调查了该人群小肠细菌过度生长(SIBO)的患病率。
2390 例 IBS 样症状患者中,848 例(35%)为症状性乳糖吸收不良,1531 例(64%)为症状性果糖吸收不良。587 例(25%)患者存在联合症状性碳水化合物吸收不良。严重果糖吸收不良患者(病理性 25 g 果糖试验)在 50 g 试验中呼出的 H2 浓度明显高于 25 g 果糖试验阴性患者(P < 0.001)。在 460/659 例乳糖和果糖试验早期 H2 显著增加的患者中进行葡萄糖呼气试验,88 例患者结果阳性提示 SIBO,且他们明显比试验结果阴性的患者年龄大(P < 0.01)。161 例患者中经上消化道内镜发现 1 例乳糜泻。
尽管通过 H2 呼气试验可以很容易地确认诊断,但在 IBS 样症状患者中,碳水化合物吸收不良是一种常见但被低估的情况。